The results we present support the potential of AChE as a future drug target against S. japonicum and also strengthens the view that immunological targeting of schistosome AChEs may be a highly suitable avenue for future vaccine development and the prevention of schistosomiasis. Here, ACHE is linked to schistosomiasis.